We found that the rate of thyroid cancer was lower in the patients prescribed GLP-1 medications, but the decrease was only statistically significant in the patients with a BMI between 30 and 35, or class 1 obesity, as shown in Figure 2
This unique mechanism has positioned it as one of the most promising investigational compounds for the treatment of obesity and type 2 diabetes in clinical research settings
This premium reflects decades of research and development, clinical trials, FDA regulatory approval processes, marketing expenses, and patent protections
The science behind GLP-1 itself is solidit helps regulate appetite and blood sugar
If you've been following the medical weight loss conversation, you already know that injectable drugs like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) have fundamentally changed how medicine approaches obesity and metabolic health
This step-by-step approach helps your body adjust and makes it easier to manage any side effects
